Haste makes waste: are the data regarding TARGIT-A IORT ready for prime time?
We would like to comment on the manuscript written by Esserman and colleagues [1] regarding the application of a decision analytic framework for adoption of clinical trial results. It is true that due to the prevalence of breast cancer, any management decision concerning its treatment may have signi...
Main Authors: | Kaidar-Person, Orit (Author), Poortmans, Philip (Author), Klimberg, Suzanne (Author), Haviland, Joanne (Author), Offersen, Birgitte (Author), Audisio, Riccardo (Author), Yarnold, John (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2014-06.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
TARGIT-E(lderly)—Prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer
by: Neumaier Christian, et al.
Published: (2012-05-01) -
The TARGIT-A Trial: understanding noninferiority and survival analysis
by: Haviland, Joanne S., et al.
Published: (2015) -
Radiotherapy for breast cancer, the TARGIT-A trial
by: Haviland, J.S, et al.
Published: (2014) -
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges
by: Orit Kaidar-Person, et al.
Published: (2021-04-01) -
Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
by: Ayelet Eran, et al.
Published: (2021-05-01)